Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

The Ischemic Penumbra,Operationally Defined by Diffusion and Perfusion MRI
Neurol 53:1528-1537, Schlaug,G.,et al, 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Intractable Seizures in Pregnancy
Lancet 354:1522, Smith,P.E.M.,et al, 1999

Sudden Unexpected Death in epilepsy (SUDEP): A Clinical Perspective and a Search for Risk Factors
JNNP 67:439-444,427, Kloster,R.&Engelskjon,T., 1999

Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999

Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999

Brief Antiepileptic Drug Withdrawal Prolongs Interval To Next Seizure
Neurol 53:1736-1741, Laowattana,S.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999

Helicopter Transfer Offers a Potential Benefit to Patients with Acute Stroke
Stroke 30:2580-2584, Conroy,M.B.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Diagnosis and Treatment of Wilson's Disease
Semin Neurol 19:261-270, Brewer,G.J.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Immunologic Treatment of Alzheimer's Disease
NEJM 341:1694-1695, Blass,J.P., 1999

Carotid Endarterectomy, Where Do We Draw The Line?
Stroke 30:1745-1750, Gorelick,P.B., 1999

Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999

Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Globus Pallidus Deep Brain Stimulation for Generalized Dystonia:Clinical and PET Investigation
Neurol 53:871-874, Kumar,R.,et al, 1999

Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999

Getting Oriented to Patient-Oriented Outcomes
Neurol 53:662-663, Vickrey,B.G., 1999

Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999

Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999

Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999

Reassessment:Vagus Nerve Stimulation for Epilepsy
Neurol 53:666-669, Fisher,R.S.&Handforth,A., 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999

When Should Heparin be Given to Patients with Atrial Fibrillation-Related Embolic Brain Infarcts?
Arch Neurol 56:1059-1060, Caplan,L.R., 1999

Heparin in Acute Stroke with Atrial Fibrillation, Clinical Relevance of Very Early Treatment
Arch Neurol 56:1098-1102,1059, Chamorro,A.,et al, 1999

Is There Still a Role for Intravenous Heparin in Acute Stroke? Yes
Arch Neurol 56:1159-1160,1162, Grau,A.J.&Hacke,W., 1999

Is There Still a Role for Intravenous Heparin in Acute Stroke? No
Arch Neurol 56:1160-1162, Sandercock,P., 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

A Randomized Trial of Risperidone,Placebo,and Haloperidol for Behavioral Symptoms of Dementia
Neurol 53:946-955,899, DeDeyn,P.P.,et al, 1999

Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999

Safety and Factors Related to Survival After Percutaneous Endoscopic Gastrostomy in ALS
Neurol 53:1123-1125, Chio,A.,et al, 1999

Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999

Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999

Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999